{"id":"https://openalex.org/W4411017374","doi":"https://doi.org/10.1016/j.esmoop.2025.105286","title":"Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer","display_name":"Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer","publication_year":2025,"publication_date":"2025-06-01","ids":{"openalex":"https://openalex.org/W4411017374","doi":"https://doi.org/10.1016/j.esmoop.2025.105286","pmid":"https://pubmed.ncbi.nlm.nih.gov/40472659"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2025.105286","doi":"https://doi.org/10.1016/j.esmoop.2025.105286","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105286","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S205970292501155X","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/action/showPdf?pii=S205970292501155X","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008139209","display_name":"Mitchell J. Elliott","orcid":"https://orcid.org/0000-0001-6711-7287","observed_orcids":["https://orcid.org/0000-0001-6711-7287"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M.J. Elliott","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103208897","display_name":"Jaegil Kim","orcid":"https://orcid.org/0000-0003-4588-5618","observed_orcids":["https://orcid.org/0000-0003-4588-5618","https://orcid.org/0000-0001-8091-095X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Kim","raw_affiliation_strings":["Precision Medicine, R&D, GSK, Collegeville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Medicine, R&D, GSK, Collegeville, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Dou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. Dou","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026882542","display_name":"Jes\u00fas Fuentes\u2010Antr\u00e1s","orcid":"https://orcid.org/0000-0001-5805-2362","observed_orcids":["https://orcid.org/0000-0001-5805-2362"]},"institutions":[{"id":"https://openalex.org/I4210109886","display_name":"Hospital Universitario Quir\u00f3nsalud Madrid","ror":"https://ror.org/018q88z15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210109886"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Fuentes Antr\u00e1s","raw_affiliation_strings":["NEXT Oncology, Hospital Universitario Quir\u00f3nsalud Madrid, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Oncology, Hospital Universitario Quir\u00f3nsalud Madrid, Madrid, Spain","institution_ids":["https://openalex.org/I4210109886"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102844847","display_name":"Eitan Amir","orcid":"https://orcid.org/0000-0002-3706-525X","observed_orcids":["https://orcid.org/0000-0002-3706-525X"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E. Amir","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089936849","display_name":"Michelle B. Nadler","orcid":"https://orcid.org/0000-0002-4372-3204","observed_orcids":["https://orcid.org/0000-0002-4372-3204"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M.B. Nadler","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089950155","display_name":"Emily Van de Laar","orcid":"https://orcid.org/0000-0002-2816-9065","observed_orcids":["https://orcid.org/0000-0002-2816-9065"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E. Van de Laar","raw_affiliation_strings":["Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062030678","display_name":"Celeste Yu","orcid":"https://orcid.org/0000-0002-8764-1091","observed_orcids":["https://orcid.org/0000-0002-8764-1091"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Yu","raw_affiliation_strings":["Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Cheikh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Cheikh","raw_affiliation_strings":["Precision Medicine, R&D, GSK, Collegeville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Medicine, R&D, GSK, Collegeville, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Silvestro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Silvestro","raw_affiliation_strings":["Precision Medicine, R&D, GSK, Collegeville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Medicine, R&D, GSK, Collegeville, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000204204","display_name":"Lillian L. Siu","orcid":"https://orcid.org/0000-0002-3500-0540","observed_orcids":["https://orcid.org/0000-0002-3500-0540"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"L.L. Siu","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P.L. Bedard","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040964442","display_name":"Hal K. Berman","orcid":"https://orcid.org/0000-0001-7524-7911","observed_orcids":["https://orcid.org/0000-0001-7524-7911"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H.K. Berman","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060911347","display_name":"David W. Cescon","orcid":"https://orcid.org/0000-0002-1080-0998","observed_orcids":["https://orcid.org/0000-0002-1080-0998"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"D.W. Cescon","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: dave.cescon@uhn.ca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: dave.cescon@uhn.ca","institution_ids":["https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5060911347"],"corresponding_institution_ids":["https://openalex.org/I2802654988"],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":5.2061,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.96554528,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"10","issue":"6","first_page":"105286","last_page":"105286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9829999804496765},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8519999980926514},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7730000019073486},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9570000171661377},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.6650000214576721},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9319999814033508},{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.9750000238418579},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.5609999895095825},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C121912465","wikidata":"https://www.wikidata.org/wiki/Q3589153","display_name":"Epigenomics","level":5,"score":0.8381587266921997},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6532005667686462},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5883840918540955},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5464989542961121},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49650412797927856},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.47655895352363586},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.47399675846099854},{"id":"https://openalex.org/C17757408","wikidata":"https://www.wikidata.org/wiki/Q4135516","display_name":"genomic DNA","level":3,"score":0.42936253547668457},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4001675844192505},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3642747700214386},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3465903401374817},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28145673871040344},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2627187967300415},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11536207795143127},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074141","descriptor_name":"Circulating Tumor DNA","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000074141","descriptor_name":"Circulating Tumor DNA","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000074141","descriptor_name":"Circulating Tumor DNA","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000074141","descriptor_name":"Circulating Tumor DNA","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D057890","descriptor_name":"Epigenomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D057890","descriptor_name":"Epigenomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.esmoop.2025.105286","doi":"https://doi.org/10.1016/j.esmoop.2025.105286","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105286","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S205970292501155X","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},{"id":"pmid:40472659","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40472659","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO open","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2025.105286","doi":"https://doi.org/10.1016/j.esmoop.2025.105286","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105286","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S205970292501155X","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6700000166893005,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1894849994","display_name":null,"funder_award_id":"UM1 CA186644","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306141","display_name":"Susan G. Komen for the Cure","ror":"https://ror.org/02nadbe75"},{"id":"https://openalex.org/F4320306239","display_name":"Conquer Cancer Foundation","ror":"https://ror.org/027327e78"},{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320311559","display_name":"Princess Margaret Cancer Foundation","ror":"https://ror.org/00ctsa544"},{"id":"https://openalex.org/F4320314126","display_name":"PTC Therapeutics","ror":"https://ror.org/03jz67a83"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320319928","display_name":"Canadian Cancer Society","ror":null},{"id":"https://openalex.org/F4320322015","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320325516","display_name":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","ror":"https://ror.org/05r1zgk22"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320329930","display_name":"Symphogen","ror":"https://ror.org/008kt5750"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"},{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"},{"id":"https://openalex.org/F4320334576","display_name":"Canadian Cancer Society Research Institute","ror":"https://ror.org/017343w90"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F496137003","display_name":"Canadian Association of Medical Oncologists","ror":"https://ror.org/05nk58x81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411017374.pdf","grobid_xml":"https://content.openalex.org/works/W4411017374.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1676308378","https://openalex.org/W2096145980","https://openalex.org/W2115961074","https://openalex.org/W2182711918","https://openalex.org/W2570341714","https://openalex.org/W2593435710","https://openalex.org/W2617211904","https://openalex.org/W2805734855","https://openalex.org/W2939548416","https://openalex.org/W2965583450","https://openalex.org/W2999400187","https://openalex.org/W3012544261","https://openalex.org/W3047825284","https://openalex.org/W3049105619","https://openalex.org/W3109124091","https://openalex.org/W3112330264","https://openalex.org/W3215275071","https://openalex.org/W3215714894","https://openalex.org/W4309773737","https://openalex.org/W4362592937","https://openalex.org/W4372336859","https://openalex.org/W4379600909","https://openalex.org/W4381714968","https://openalex.org/W4389554753","https://openalex.org/W4390660487","https://openalex.org/W4392634101","https://openalex.org/W4406229659","https://openalex.org/W4407843020"],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2795212387","https://openalex.org/W2988805143","https://openalex.org/W4285490847","https://openalex.org/W3201524181","https://openalex.org/W2101726782","https://openalex.org/W2946746360","https://openalex.org/W2606237140","https://openalex.org/W2100856525","https://openalex.org/W2119272378"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,115,195],"detection":[2,119,136,201,277],"of":[3,20,38,59,144,159,170,233,256,271,278,282],"circulating":[4],"tumor":[5],"DNA":[6],"(ctDNA)":[7],"after":[8],"curative-intent":[9],"therapy,":[10],"referred":[11],"to":[12,202,252,285],"as":[13],"molecular/minimal":[14],"residual":[15],"disease":[16,21],"(MRD),":[17],"is":[18,67],"prognostic":[19,169,226],"recurrence":[22,145,190,204],"in":[23,35,50,162,220,239,246,289],"early-stage":[24,87],"breast":[25,99],"cancer":[26,40,100,241],"(EBC).":[27],"Tumor-agnostic":[28],"approaches":[29],"that":[30],"rely":[31],"on":[32],"mutation-based":[33],"assessment":[34,281],"fixed":[36],"panels":[37],"common":[39,240],"driver":[41,242],"genes":[42],"have":[43],"shown":[44],"limited":[45,64,229],"utility":[46,288],"for":[47,189,275],"detecting":[48],"MRD":[49,53,61],"EBC.":[51],"Methylation-based":[52],"(mMRD)":[54,120,137,161],"may":[55],"overcome":[56],"the":[57,163,225,276],"limitations":[58],"genomic-based":[60],"(gMRD),":[62],"though":[63],"clinical":[65,203,287],"validation":[66],"available.":[68],"MATERIALS":[69],"AND":[70],"METHODS:":[71],"To":[72],"investigate":[73],"this,":[74],"we":[75],"analyzed":[76],"290":[77],"longitudinally":[78],"banked":[79],"plasma":[80],"samples":[81],"from":[82,199,213],"95":[83],"participants":[84,127],"diagnosed":[85],"with":[86,140,183],"estrogen":[88],"receptor":[89,94],"(ER)-positive/human":[90],"epidermal":[91],"growth":[92],"factor":[93],"2-negative":[95],"(ER-positive)":[96],"and":[97,109,165,186,258,280],"triple-negative":[98],"(TNBC)":[101],"undergoing":[102],"neoadjuvant":[103],"chemotherapy":[104],"using":[105],"a":[106,141],"high-sensitivity":[107],"genomic":[108],"epigenomic-based,":[110],"tumor-agnostic":[111,272],"ctDNA":[112,118,135,160,279],"platform.":[113],"RESULTS:":[114],"baseline":[116],"(pre-chemotherapy)":[117],"rate":[121],"was":[122,138,205,218,228],"72.5%":[123],"(66/91)":[124],"across":[125],"all":[126,221],"(ER-positive:":[128],"33/48,":[129],"69%;":[130],"TNBC:":[131],"33/43,":[132],"77%).":[133],"Baseline":[134],"associated":[139],"higher":[142],"risk":[143],"[hazard":[146],"ratio":[147],"(HR)":[148],"9.4,":[149],"95%":[150,177],"confidence":[151],"interval":[152],"(CI)":[153],"1.3-70.3,":[154],"P":[155,180],"=":[156],"0.03].":[157],"Detection":[158],"post-operative":[164],"follow-up":[166],"periods":[167],"were":[168],"worse":[171],"event-free":[172],"survival":[173],"(EFS)":[174],"(HR":[175],"17.0,":[176],"CI":[178],"6.0-48.0,":[179],"<":[181],"0.0001)":[182],"62.5%":[184],"sensitivity":[185],"100%":[187],"specificity":[188],"(positive":[191],"predictive":[192],"value":[193,227],"100%).":[194],"median":[196],"lead":[197],"time":[198,223],"mMRD":[200,257,263,273],"152":[206],"days":[207],"(range":[208],"15-748":[209],"days).":[210],"gMRD,":[211],"derived":[212],"plasma-only":[214],"panel-based":[215],"next-generation":[216],"sequencing,":[217],"evaluated":[219],"matched":[222],"points;":[224],"by":[230],"clonal":[231],"hematopoiesis":[232],"indeterminate":[234],"potential,":[235],"including":[236],"pathogenic":[237],"mutations":[238],"genes.":[243],"Despite":[244],"refinements":[245],"gMRD":[247,259],"analysis,":[248],"it":[249],"remained":[250],"inferior":[251],"mMRD.":[253],"A":[254],"combination":[255],"did":[260],"not":[261],"outperform":[262],"alone.":[264],"CONCLUSION:":[265],"These":[266],"results":[267],"support":[268],"further":[269],"development":[270],"assays":[274,284],"these":[283],"develop":[286],"this":[290],"setting.":[291]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}